Skip to search.
 TSX Up 0.06% TSX Ventures Up 0.46%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.61 Down 0.09(3.33%) Aug 26, 4:00PM EDT
|After Hours : 2.61 0.00 (0.00%) Aug 26, 4:33PM EDT
Prev Close:2.70
Open:2.72
Bid:2.61 x 100
Ask:3.00 x 1400
1y Target Est:6.40
Beta:1.10838
Earnings Date:Nov 1 - Nov 7 (Est.)
Day's Range:2.57 - 2.75
52wk Range:1.88 - 3.68
Volume:851,661
Avg Vol (3m):643,678
Market Cap:246.88M
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 3.33%246.88M
AMGNUp 1.02%128.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.75
Quarterly EPS Est (Sep-16) :-0.20
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback